ATLASBone Biologics (BBLG) earnings date: expected January 4–10
Bone Biologics (BBLG) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 4–10. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on BBLG
| Last price | $0.38 (-2.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.1% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 6 reports |
These figures come from the same calibrated model and valuation as the Bone Biologics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 4–10 (estimate). One email the day before, with ATLAS’s read on Bone Biologics. You can switch it off at any time.
Alert me before BBLG reportsFree to start. Creating an account takes under a minute.
Notify me when Bone Biologics reports
Track BBLG free Add Bone Biologics to a free ATLAS watchlist and see its next report date in one place.
BBLG earnings at a glance
| Next report | Not announced · expected around January 4–10 (ATLAS estimate) |
|---|---|
| Last report | Oct 26, 2026 · Beat |
| Beat rate (last 6 reports) | 3 of 6 (50%) |
| Average EPS surprise | -35.4% |
| Average move around a report | ±5.9% (last 6) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between Bone Biologics’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Bone Biologics earnings history: last 6 reports
Bone Biologics last reported on Oct 26, 2026: EPS of -$0.17 against an estimate of -$0.19 (+10.5% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 26, 2026 | -$0.19 | -$0.17 | +10.5% | Beat | -6.8% |
| Aug 14, 2026 | -$0.39 | -$0.43 | -10.3% | Miss | -2.1% |
| Jul 28, 2026 | $0.87 | $0.89 | +2.3% | Beat | -11.7% |
| May 14, 2026 | -$0.54 | -$0.43 | +20.4% | Beat | -2.3% |
| Mar 24, 2026 | -$0.40 | -$1.00 | -150.0% | Miss | -3.4% |
| Mar 2, 2026 | -$0.34 | -$0.63 | -85.3% | Miss | +9.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for BBLG
See the fair value, the probability range and the earnings history of Bone Biologics on its ATLAS page.
Bone Biologics (BBLG) stock analysisPlans from €3.99 a month.
Bone Biologics earnings: frequently asked questions
When is Bone Biologics (BBLG) next earnings date?
Bone Biologics has not announced its next report. Its last 4 reports came Oct 26, 2026, Aug 14, 2026, May 14, 2026, Mar 2, 2026, so ATLAS estimates the next one around January 4–10. This is an estimate based on that pattern, not a confirmed date.
How often does BBLG beat earnings estimates?
Of its last 6 reports with a recorded result, Bone Biologics beat the EPS estimate 3 times; the average surprise was -35.4%. Past results do not predict the next one.
How much does BBLG move around earnings?
Over its last 6 reports the stock moved an average of 5.9% (absolute, from the close before the report day to the close after it), and finished higher 1 of 6 times.
Did Bone Biologics beat earnings estimates last quarter?
Bone Biologics last reported on Oct 26, 2026: EPS of -$0.17 against an estimate of -$0.19 (+10.5% surprise), a beat.
How much does BBLG usually move in a day?
On a normal trading day the ATLAS model puts BBLG’s one-day range at about ±4.1%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer